Azitra Inc.
Clinical trials sponsored by Azitra Inc., explained in plain language.
-
New cream may soothe rash from cancer drugs
Symptom relief Recruiting nowThis study tests a topical cream called ATR04-484 for skin rash caused by EGFR inhibitor cancer therapy. About 32 adults with moderate to severe rash will apply the cream or a placebo daily for 28 days. The main goal is to see if the cream is safe and helps clear the rash.
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated May 17, 2026 17:19 UTC
-
New cream shows promise for rare skin disorder
Symptom relief Recruiting nowThis early-stage study tests a new cream called ATR12-351 in 12 adults with Netherton Syndrome, a rare genetic skin condition. The cream is applied to skin lesions twice daily for two weeks, with a placebo cream used on other areas for comparison. The main goals are to check safe…
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC